The narrow QRS tachycardia is that which originates above the His bundle bifurcation, with QRS complexes of less than 120 ms and heart rate of more than 100 beats per minute (bpm). Its prevalence in the general population is 6 to 8/1000 individuals, reaching 11% to 18% in patients with heart failure [1]. Among children the duration of the QRS of the tachycardia is equal to or less than 90 seconds and heart rate can exceed 200 bpm in newborn infants and higher than 100 bpm (from 130 to 300 bpm) in those over 10 years of age [1,2].Among the regular narrow QRS tachycardia, the most common is typical atrioventricular (AV) nodal reentrant tachycardia, followed by orthodromic AV tachycardia. Symptoms include palpitations, fatigue, chest pain, light-headedness, neck discomfort, polyuria and pre-syncope and syncope. Polyuria is due to the natriuretic peptide secreted by the distension of the atria. Syncope can occur between 15% and 20% of patients, due to the high rate of the tachyarrhythmia (≥ 170 bpm). Besides this morbidity, these tachycardias can lead Paroxysmal supraventricular tachycardias with narrow QRS are defined as rhythms originating from above the His bundle, heart rate higher 100 bpm and QRS complex of less than 120 ms in adults or less than 90 ms in children. They present a prevalence of up to 8/1000 individuals. The main presentations of these regular tachycardias are atrioventricular nodal re-entrant tachycardia and orthodromic atrioventricular reentrant tachycardia due to an accessory pathway. These tachycardias present morbidity, with symptoms such as palpitations, dyspnea, chest pain, syncope, polyuria, and can be a cause of sudden cardiac death. Thus, their clinical and electrocardiographic diagnoses are the first step in the approach and treatment of the patient. This review will discuss the clinical aspects, electrocardiographic, electrophysiological diagnosis and treatment options in the acute phase and long-term management, in addition to nonpharmacological treatment.